Dr. Cheng received her medical degree at the School of Medicine and Biomedical Sciences at University of Buffalo, followed by an internal medicine residency at Rush University Medical Center in Chicago. She then completed a fellowship in endocrinology, diabetes, and metabolism at University of California San Francisco and participated in a non-ACGME fellowship in bone and mineral disorders at Washington University in St Louis. Prior to joining Labcorp, she worked as a clinical endocrinologist at Northeast Community Clinic in Los Angeles. Her areas of expertise include general endocrinology and NASH.
Dr. Cheng is a member of the Endocrine Society and American Association of Clinical Endocrinologists (AACE), and have co-authored several peer-reviewed publications in the field of endocrinology.
Publications
- Folick A, Cheng C, Chu SN, Rick JW, Rushakoff RJ. Discordant Timing of Hypoglycemic Agent Screening Causing Delayed Diagnosis of Sulfonylurea-Induced Hypoglycemia. AACE Clin Case Rep. 2022 Jan 3;8(3):139-141. doi: 10.1016/j.aace.2021.12.006
- Cheng C, Wentworth K, Shoback DM. New Frontiers in Osteoporosis Therapy. Annu Rev Med. 2020 Jan 27;71:277-288. doi: 10.1146/annurev-med-052218-020620
- Kim BW, Yousman W, Wong WX, Cheng C, McAninch EA. Less is More: Comparing the 2015 and 2009 American Thyroid Association Guidelines for Thyroid Nodules and Cancer. Thyroid. 2016 Jun;26(6):759-64. doi: 10.1089/thy.2016.0068
Specialties: Endocrinology